IL1RAP and leukemia: In chronic myeloid leukemia (CML), recombinant antibodies targeting IL-1 receptor antagonist (IL-1RA) and IL-1 receptor accessory protein (IL1RAP) can block IL-1 signaling in CML leukemia stem cells (LSCs) and inhibit their growth (85, 86).